Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
about
Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cellsPredicting portal hypertension as assessed by acoustic radiation force impulse: correlations with the Doppler ultrasound.Expression of subtypes of somatostatin receptors in hepatic stellate cellsClinical pharmacology of portal hypertension.Current management of the complications of portal hypertension: variceal bleeding and ascites.Mechanisms of liver injury relevant to pediatric hepatology.Therapeutic potential of targeting the renin angiotensin system in portal hypertension.Hepatic stellate cells may be potential effectors of platelet activating factor induced portal hypertensionSynthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosisLiver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).New cellular and molecular targets for the treatment of portal hypertension.Emerging therapies for portal hypertension in cirrhosis.Sinusoidal communication in liver fibrosis and regeneration.IL-20 and IL-20R1 antibodies protect against liver fibrosis.Fibrillin-1 expression in normal and fibrotic rat liver and in cultured hepatic fibroblastic cells: modulation by mechanical stress and role in cell adhesion.Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts.Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis.Endothelin and vascular function in liver diseaseDose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells.Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies.Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologistsAdenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver.Is transient elastography valuable for high-risk esophageal varices prediction in patients with hepatitis-B-related cirrhosis?Hepatic stellate cell activation in vitro: cell cycle arrest at G2/M and modification of cell motility.Long-term administration of Salvia miltiorrhiza ameliorates carbon tetrachloride-induced hepatic fibrosis in rats.Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis.Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.Evaluation of glial fibrillar acidic protein as a marker of hepatic ischemia-reperfusion.The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.Chronic liver disease: Correlation of CEUS-based microperfusion and indocyanine green clearance.Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion.Interleukin (IL)-13, Prostaglandin E2 (PGE2), and Prostacyclin 2 (PGI2) Activate Hepatic Stellate Cells via Protein kinase C (PKC) Pathway in Hepatic Fibrosis.
P2860
Q24291164-57EA1138-1383-4BD4-B29E-F8089BEA23A3Q30451338-66FA7571-EC71-44AC-8225-2B7512811519Q31066268-DB54746A-A73A-4BA5-BF0B-826CAED44E6AQ34399357-E9ED680F-A0D0-4C86-A1C7-C8015DFE5A47Q34523099-BE4E2F36-A8CA-4F99-AAFE-347E8C4D7F0FQ34559789-23DC7648-2538-4B6C-B9E2-B3AD4247AB3CQ36769062-78A1DA09-ECD8-4ABC-A543-65E459C37CEEQ37174141-030E0400-0D70-463E-A19C-DFE7844CC7ECQ37196900-DE727437-0444-4CA9-BEBA-922836BCAC92Q37577564-34E750E2-097D-4C78-8068-9F2BC1E3F460Q38383418-AC2B1AD4-B634-46AB-90E3-88F72B9F3138Q38826464-56C6A8BC-09A0-4C88-A509-6F9F1925A1E9Q38827092-76AA42CF-7E39-4F4B-A061-062ED536844BQ39001343-68270C71-F25F-47A0-BEF6-2538A11DB68AQ40609664-6AAFAF51-87C5-41AB-B801-A45CCA1815AAQ40732903-302B1A99-F39C-4157-ABA4-03018CB56355Q41773351-8A4C9957-D8FB-4CA5-991E-B015ACC0E201Q41919923-43C6EC0E-E13C-4CFD-85C0-A6E9E1AAF841Q42091993-5D50CCEE-3182-4688-BB78-CA505D91EB37Q42206856-E89A3ED1-153C-472A-8261-459E215DBAD3Q42379057-CC6EBDDB-13CF-4764-B227-007066891FF4Q43884266-043880AE-3F1C-42AB-99D9-139126F1A3B4Q44445547-2FBAC734-18ED-46F7-A1CE-75D72AFFA5E8Q44593468-B68D3CE7-2796-4781-AA4A-B3D55A1FA8C4Q44720810-EB2CA35D-C16E-4A90-B224-DF519BCC545DQ45154752-A7E12ACC-D10A-43DE-878C-BE689D1800E2Q46169180-A216F2D8-2F8D-46A5-8878-E3A7646444DBQ46391156-C08D54F0-52B4-416E-91E8-C9B71764AFDCQ47866697-0C328335-43B6-49FD-A571-7F34B92F9316Q48292789-2BB7345B-F50E-488F-BBF0-528CF1DCDA43Q50244030-27DBFCB7-66FE-4DE3-91BF-CBEC69FF0943Q51061884-B844E560-1029-4B77-8FDA-9E83832A7D3DQ54116768-32B192CA-846C-427B-8B61-89B00CDCC9DB
P2860
Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Biology of hepatic stellate ce ...... tal hypertension in cirrhosis.
@ast
Biology of hepatic stellate ce ...... tal hypertension in cirrhosis.
@en
type
label
Biology of hepatic stellate ce ...... tal hypertension in cirrhosis.
@ast
Biology of hepatic stellate ce ...... tal hypertension in cirrhosis.
@en
prefLabel
Biology of hepatic stellate ce ...... tal hypertension in cirrhosis.
@ast
Biology of hepatic stellate ce ...... tal hypertension in cirrhosis.
@en
P356
P1476
Biology of hepatic stellate ce ...... tal hypertension in cirrhosis.
@en
P2093
Gentilini P
P304
P356
10.1055/S-2007-1007128
P577
1999-01-01T00:00:00Z